109 related articles for article (PubMed ID: 32044421)
1. Dose assessment for patients with stage I non-small cell lung cancer receiving passive scattering carbon-ion radiotherapy using daily computed tomographic images: A prospective study.
Li Y; Kubota Y; Kubo N; Mizukami T; Sakai M; Kawamura H; Irie D; Okano N; Tsuda K; Matsumura A; Saitoh JI; Nakano T; Ohno T
Radiother Oncol; 2020 Mar; 144():224-230. PubMed ID: 32044421
[TBL] [Abstract][Full Text] [Related]
2. Robustness of patient positioning for interfractional error in carbon ion radiotherapy for stage I lung cancer: Bone matching versus tumor matching.
Sakai M; Kubota Y; Saitoh JI; Irie D; Shirai K; Okada R; Torikoshi M; Ohno T; Nakano T
Radiother Oncol; 2018 Oct; 129(1):95-100. PubMed ID: 29100701
[TBL] [Abstract][Full Text] [Related]
3. Robustness of daily dose for each beam angle and accumulated dose for inter-fractional anatomical changes in passive carbon-ion radiotherapy for pancreatic cancer: Bone matching versus tumor matching.
Kubota Y; Okamoto M; Shiba S; Okazaki S; Matsui T; Li Y; Itabashi Y; Sakai M; Kubo N; Tsuda K; Ohno T; Nakano T
Radiother Oncol; 2021 Apr; 157():85-92. PubMed ID: 33515667
[TBL] [Abstract][Full Text] [Related]
4. Technical Note: Predicting dose distribution with replacing stopping power ratio for inter-fractional motion and intra-fractional motion during carbon ion radiotherapy with passive irradiation method for stage I lung cancer.
Kubota Y; Sakai M; Tashiro M; Saitoh JI; Abe T; Ohno T; Nakano T
Med Phys; 2018 Jul; 45(7):3435-3441. PubMed ID: 29757472
[TBL] [Abstract][Full Text] [Related]
5. Adaptive planning based on single beam optimization in passive scattering carbon ion radiotherapy for patients with pancreatic cancer.
Li Y; Kubota Y; Okamoto M; Shiba S; Okazaki S; Matsui T; Tashiro M; Nakano T; Ohno T
Radiat Oncol; 2021 Jun; 16(1):111. PubMed ID: 34147099
[TBL] [Abstract][Full Text] [Related]
6. Verification of Dose Distribution in Carbon Ion Radiation Therapy for Stage I Lung Cancer.
Irie D; Saitoh JI; Shirai K; Abe T; Kubota Y; Sakai M; Noda SE; Ohno T; Nakano T
Int J Radiat Oncol Biol Phys; 2016 Dec; 96(5):1117-1123. PubMed ID: 27869084
[TBL] [Abstract][Full Text] [Related]
7. Feasibility of dynamic adaptive passive scattering proton therapy with computed tomography image guidance in the lung.
Moriya S; Tachibana H; Hotta K; Nakamura N; Sakae T; Akimoto T
Med Phys; 2017 Sep; 44(9):4474-4481. PubMed ID: 28665491
[TBL] [Abstract][Full Text] [Related]
8. Comparison between bone matching and marker matching for evaluation of intra- and inter-fractional changes in accumulated dose of carbon ion radiotherapy for hepatocellular carcinoma.
Kubota Y; Katoh H; Shibuya K; Shiba S; Abe S; Sakai M; Yuasa D; Tsuda K; Ohno T; Nakano T
Radiother Oncol; 2019 Aug; 137():77-82. PubMed ID: 31078014
[TBL] [Abstract][Full Text] [Related]
9. Variations of target volume definition and daily target volume localization in stereotactic body radiotherapy for early-stage non-small cell lung cancer patients under abdominal compression.
Han C; Sampath S; Schultheisss TE; Wong JYC
Med Dosim; 2017 Summer; 42(2):116-121. PubMed ID: 28433482
[TBL] [Abstract][Full Text] [Related]
10. Increased therapeutic ratio by 18FDG-PET CT planning in patients with clinical CT stage N2-N3M0 non-small-cell lung cancer: a modeling study.
van Der Wel A; Nijsten S; Hochstenbag M; Lamers R; Boersma L; Wanders R; Lutgens L; Zimny M; Bentzen SM; Wouters B; Lambin P; De Ruysscher D
Int J Radiat Oncol Biol Phys; 2005 Mar; 61(3):649-55. PubMed ID: 15708242
[TBL] [Abstract][Full Text] [Related]
11. A potential to reduce pulmonary toxicity: the use of perfusion SPECT with IMRT for functional lung avoidance in radiotherapy of non-small cell lung cancer.
Lavrenkov K; Christian JA; Partridge M; Niotsikou E; Cook G; Parker M; Bedford JL; Brada M
Radiother Oncol; 2007 May; 83(2):156-62. PubMed ID: 17493699
[TBL] [Abstract][Full Text] [Related]
12. A study of the anatomic changes and dosimetric consequences in adaptive CRT of non-small-cell lung cancer using deformable CT and CBCT image registration.
Ma C; Hou Y; Li H; Li D; Zhang Y; Chen S; Yin Y
Technol Cancer Res Treat; 2014 Apr; 13(2):95-100. PubMed ID: 23919391
[TBL] [Abstract][Full Text] [Related]
13. Dosimetric comparison of stereotactic body radiotherapy using 4D CT and multiphase CT images for treatment planning of lung cancer: evaluation of the impact on daily dose coverage.
Wang L; Hayes S; Paskalev K; Jin L; Buyyounouski MK; Ma CC; Feigenberg S
Radiother Oncol; 2009 Jun; 91(3):314-24. PubMed ID: 19111362
[TBL] [Abstract][Full Text] [Related]
14. Changes in the radiological depth correlate with dosimetric deterioration in particle therapy for stage I NSCLC patients under high frequency jet ventilation.
Santiago A; Fritz P; Mühlnickel W; Engenhart-Cabillic R; Wittig A
Acta Oncol; 2015; 54(9):1631-7. PubMed ID: 26228661
[TBL] [Abstract][Full Text] [Related]
15. Dosimetric evaluation of 4D-CBCT reconstructed by Simultaneous Motion Estimation and Image Reconstruction (SMEIR) for carbon ion therapy of lung cancer.
Shrestha D; Tsai MY; Qin N; Zhang Y; Jia X; Wang J
Med Phys; 2019 Sep; 46(9):4087-4094. PubMed ID: 31299097
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of adaptive treatment planning for patients with non-small cell lung cancer.
Zhong H; Siddiqui SM; Movsas B; Chetty IJ
Phys Med Biol; 2017 Jun; 62(11):4346-4360. PubMed ID: 28072395
[TBL] [Abstract][Full Text] [Related]
17. Combined PET/CT for IMRT treatment planning of NSCLC: contrast-enhanced CT images for Monte Carlo dose calculation.
Mönnich D; Lächelt S; Beyer T; Werner MK; Thorwarth D
Phys Med; 2013 Nov; 29(6):644-9. PubMed ID: 22975430
[TBL] [Abstract][Full Text] [Related]
18. Potential of adaptive radiotherapy to escalate the radiation dose in combined radiochemotherapy for locally advanced non-small cell lung cancer.
Guckenberger M; Wilbert J; Richter A; Baier K; Flentje M
Int J Radiat Oncol Biol Phys; 2011 Mar; 79(3):901-8. PubMed ID: 20708850
[TBL] [Abstract][Full Text] [Related]
19. Potential Pitfalls of a Fiducial Marker-matching Technique in Carbon-ion Radiotherapy for Lung Cancer.
Shiba S; Saitoh JI; Irie D; Shirai K; Abe T; Kubota Y; Sakai M; Okada R; Ohno T; Nakano T
Anticancer Res; 2017 Oct; 37(10):5673-5680. PubMed ID: 28982885
[TBL] [Abstract][Full Text] [Related]
20. Additional PET/CT in week 5-6 of radiotherapy for patients with stage III non-small cell lung cancer as a means of dose escalation planning?
Gillham C; Zips D; Pönisch F; Evers C; Enghardt W; Abolmaali N; Zöphel K; Appold S; Hölscher T; Steinbach J; Kotzerke J; Herrmann T; Baumann M
Radiother Oncol; 2008 Sep; 88(3):335-41. PubMed ID: 18514339
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
